JP4540568B2 - Method for producing L-carnosine - Google Patents

Method for producing L-carnosine Download PDF

Info

Publication number
JP4540568B2
JP4540568B2 JP2005215661A JP2005215661A JP4540568B2 JP 4540568 B2 JP4540568 B2 JP 4540568B2 JP 2005215661 A JP2005215661 A JP 2005215661A JP 2005215661 A JP2005215661 A JP 2005215661A JP 4540568 B2 JP4540568 B2 JP 4540568B2
Authority
JP
Japan
Prior art keywords
carnosine
crude
activated carbon
alcohol
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2005215661A
Other languages
Japanese (ja)
Other versions
JP2007031328A (en
JP2007031328A5 (en
Inventor
健次 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokuyama Corp
Original Assignee
Tokuyama Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokuyama Corp filed Critical Tokuyama Corp
Priority to JP2005215661A priority Critical patent/JP4540568B2/en
Publication of JP2007031328A publication Critical patent/JP2007031328A/en
Publication of JP2007031328A5 publication Critical patent/JP2007031328A5/ja
Application granted granted Critical
Publication of JP4540568B2 publication Critical patent/JP4540568B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Description

本発明は、不純物を含むL−カルノシンの粗体を精製することにより高純度L−カルノシンを製造する方法に関する。   The present invention relates to a method for producing high-purity L-carnosine by purifying a crude L-carnosine containing impurities.

L−カルノシンはβ−アラニンとL−ヒスチジンから合成されるジペプチドであり、組織修復促進作用、免疫調整作用、抗炎症作用を有していることから、医薬品や健康食品などの需要が高まっている。また、容易に金属とキレート結合をつくることから、亜鉛と錯形成したポラプレジンクなどの抗潰瘍薬、味覚障害治療薬へ応用されている。これら医薬品に使用されるL−カルノシンは高純度のものでなければならず、一般的には99.5%以上の純度が要求される。   L-carnosine is a dipeptide synthesized from β-alanine and L-histidine, and has a tissue repair promoting action, an immunomodulating action, and an anti-inflammatory action, so that demand for pharmaceuticals, health foods and the like is increasing. . In addition, since it easily forms a chelate bond with a metal, it has been applied to antiulcer drugs such as polaprezinc complexed with zinc and therapeutic agents for taste disorders. The L-carnosine used in these pharmaceuticals must have a high purity, and generally a purity of 99.5% or more is required.

前記したようにL−カルノシンは、β−アラニン又はその誘導体とL−ヒスチジン又はその誘導体とを原料として合成されるが、反応により得られるL−カルノシン粗体の精製には、一般に晶析が採用されている。(非特許文献1、2、及び3参照)。   As described above, L-carnosine is synthesized using β-alanine or a derivative thereof and L-histidine or a derivative thereof as raw materials, but crystallization is generally employed for purification of the crude L-carnosine obtained by the reaction. Has been. (See Non-Patent Documents 1, 2, and 3.)

Chemical and Pharmaceutical Bulletin 38 (11) p3140−3146 (1990)Chemical and Pharmaceutical Bulletin 38 (11) p3140-3146 (1990) Journal of Organic Chemistry 48p393−395 (1983)Journal of Organic Chemistry 48p393-395 (1983) Journal of the American Chemical Society (75) p2511−2512 (1953)Journal of the American Chemical Society (75) p2511-2512 (1953)

一般に、L−カルノシンの粗体に含まれる不純物は、極性などL−カルノシンと非常に似ている挙動を示すため、精製が困難である。このため、十分な純度まで精製を行うと収率が低くなってしまうという問題があった。例えば前記非特許文献3では、水とエタノールの混合溶液により再結晶をし、精製されたL−カルノシンの結晶を析出させているが、この時の収率は65%と低い。   In general, impurities contained in the crude L-carnosine are very similar to L-carnosine in terms of polarity and are difficult to purify. For this reason, there was a problem that the yield would be low if purification to a sufficient purity was performed. For example, in Non-Patent Document 3, recrystallization is performed with a mixed solution of water and ethanol to precipitate purified L-carnosine crystals, but the yield at this time is as low as 65%.

そこで、本発明は、高純度のL−カルノシンを効率よく製造する方法を提供することを目的とする。   Accordingly, an object of the present invention is to provide a method for efficiently producing high-purity L-carnosine.

本発明は、上記課題を解決するものであり、不純物を含むL−カルノシンの粗体を精製する精製工程を含むL−カルノシンの製造方法であって、前記精製工程が、前記粗体の水溶液とアルコールとを混合して得られた混合溶液にL−カルノシンの種結晶を添加し、30℃〜80℃で1〜10時間熟成(ripening)させる熟成工程と、前記工程で熟成された混合溶液にアルコールを加え、高純度化されたL−カルノシン結晶を析出させる結晶析出工程とを、含むことを特徴とする。   The present invention solves the above-described problem, and is a method for producing L-carnosine including a purification step of purifying a crude L-carnosine containing impurities, wherein the purification step includes an aqueous solution of the crude body. A ripening step of adding a seed crystal of L-carnosine to a mixed solution obtained by mixing alcohol and ripening at 30 to 80 ° C. for 1 to 10 hours; and the mixed solution aged in the step A crystal precipitation step of adding an alcohol to precipitate highly purified L-carnosine crystals.

本発明の製造方法によれば、L−カルノシンを高純度、高収率で得ることができる。   According to the production method of the present invention, L-carnosine can be obtained with high purity and high yield.

本発明の製造方法は、不純物を含むL−カルノシンの粗体を精製する精製工程を含む。該精製工程の原料となる粗体としては、従来の製法、即ち、β−アラニン又はその誘導体とL−ヒスチジン又はその誘導体とを原料として合成された粗体が特に制限無く使用できる。しかしながら、ヒスチジンからの収率が例えば90%と非常に高く、しかも粗体自体の純度(ここで、純度とは高速液体クロマトグラフィー(HPLC)分析を行った時に得られるチャートにおけるピーク面積を基準とする純度を意味する。以下同じ。)が98%以上と高いことから、フタロイル−β―アラニンの酸クロライドとトリメチルシリル基で保護されたL−ヒスチジンとを反応させて得たフタロイル−L−カルノシンをヒドラジンで脱保護する方法より得られた粗体を使用するのが好適である。該方法については、例えばDokladi na Bulgarskata Akademiya na Naukite 44 (8) p53−56 (1991)に記載されているが、その概要を以下に説明する。   The production method of the present invention includes a purification step of purifying a crude L-carnosine containing impurities. As a crude material used as a raw material for the purification step, a conventional production method, that is, a crude product synthesized using β-alanine or a derivative thereof and L-histidine or a derivative thereof as raw materials can be used without particular limitation. However, the yield from histidine is very high, for example, 90%, and the purity of the crude product itself (where purity refers to the peak area in the chart obtained when performing high performance liquid chromatography (HPLC) analysis). Phthaloyl-L-carnosine obtained by reacting an acid chloride of phthaloyl-β-alanine with L-histidine protected with a trimethylsilyl group is high. It is preferable to use a crude product obtained by a method of deprotecting with hydrazine. This method is described in, for example, Dokladina na Bulgarska Akademiya na Naukite 44 (8) p53-56 (1991), the outline of which will be described below.

上記粗体の製造方法で使用されるフタロイル−β−アラニンは、試薬或いは工業原料を使用することもできるが、Journal of the American Chemical Society (75) p2388−2390 (1953)に記載されているように無水フタル酸とβ−アラニンを高温下反応させる事で得ることも可能である。   The phthaloyl-β-alanine used in the above-mentioned crude production method may be a reagent or an industrial raw material, but is described in Journal of the American Chemical Society (75) p2388-2390 (1953). It is also possible to obtain it by reacting phthalic anhydride and β-alanine at high temperature.

フタロイル−β−アラニンの酸クロライド化は、二塩化オキサリルもしくは塩化チオニルと反応させる事で得られる。この場合、トルエンやジクロロメタンなどの溶媒下、フタロイル−β−アラニンに対して1〜30当量の二塩化オキサリルもしくは塩化チオニルを滴下し、溶媒還流下で行ってもよいし、無溶媒下で20〜100℃で反応を行っても良い。反応後は残留する二塩化オキサリルなどを溶媒留去することでフタロイル−β−アラニンの酸クロライドが得られる。   Acid chloride of phthaloyl-β-alanine can be obtained by reacting with oxalyl dichloride or thionyl chloride. In this case, 1 to 30 equivalents of oxalyl dichloride or thionyl chloride may be added dropwise to phthaloyl-β-alanine in a solvent such as toluene or dichloromethane, and the reaction may be performed under reflux of the solvent, or 20 to 20 in the absence of solvent. You may react at 100 degreeC. After the reaction, residual oxalyl dichloride and the like are distilled off to obtain phthaloyl-β-alanine acid chloride.

また、前記方法で使用されるトリメチルシリル基で保護されたL−ヒスチジンは、次のように合成される。即ち、硫酸触媒下、3〜10当量の1,1,1,3,3,3−ヘキサメチルジシラザン中で還流下反応させ、pH調節後、キシレンなどの溶媒を加え、溶媒留去し、ジクロロメタン、クロロホルムなどのハロゲン化溶媒で再結晶によりトリメチルシリル基で保護されたL−ヒスチジンを得る。   Further, L-histidine protected with a trimethylsilyl group used in the above method is synthesized as follows. That is, the reaction was carried out under reflux in 3 to 10 equivalents of 1,1,1,3,3,3-hexamethyldisilazane under a sulfuric acid catalyst. After pH adjustment, a solvent such as xylene was added, and the solvent was distilled off. L-histidine protected with a trimethylsilyl group is obtained by recrystallization from a halogenated solvent such as dichloromethane or chloroform.

前記粗体の製造方法では、上記のようにして得られたフタロイル−β−アラニンの酸クロライドとトリメチルシリル基で保護されたL−ヒスチジンとを、ジクロロメタン、クロロホルムなどのハロゲン化溶媒下混合し、室温で反応させることにより、フタロイル−L−カルノシン塩酸塩を得る。そして、得られたフタロイル−L−カルノシン塩酸塩をアルコール中で、水酸化リチウム1水和物などのアルカリで中和しすることにより、フタロイル−L−カルノシンとし、これを水中でヒドラジン水和物により脱保護し、酢酸処理した後にpH調節することにより、L−カルノシンの粗体を含む反応液を得ることができる。   In the crude production method, the acid chloride of phthaloyl-β-alanine obtained as described above and L-histidine protected with a trimethylsilyl group were mixed in a halogenated solvent such as dichloromethane or chloroform, To give phthaloyl-L-carnosine hydrochloride. The obtained phthaloyl-L-carnosine hydrochloride is neutralized with an alkali such as lithium hydroxide monohydrate in alcohol to obtain phthaloyl-L-carnosine, which is hydrazine hydrate in water. The reaction solution containing a crude product of L-carnosine can be obtained by deprotection by pH and adjusting pH after acetic acid treatment.

このようにして得られた粗体を含む反応液(水溶液)はそのまま、或いは水を添加することにより濃度調整を行って精製工程に供することができるが、多量に含まれる副生物を除去するために精製工程に供する前に一旦単離するのがこのましい。例えば、前記した方法で得られる粗体の反応液(水溶液)には、フタルヒドラジド等のヒドラジン由来の副生成物が多く含まれるが、該反応液から水を留去した後、残渣をアルコールで再沈殿することにより、これらヒドラジン由来の副生成物が除去されたL−カルノシンの粗体を得ることができる。このようにして単離された粗体は通常、95〜98%程度の純度を有する。   The reaction solution (aqueous solution) containing the crude product thus obtained can be used for the purification step as it is or by adjusting the concentration by adding water, but in order to remove a large amount of by-products. It is preferable to isolate it once before subjecting it to the purification step. For example, the crude reaction solution (aqueous solution) obtained by the above-described method contains many by-products derived from hydrazine such as phthalhydrazide. After distilling off water from the reaction solution, the residue is removed with alcohol. By reprecipitation, a crude product of L-carnosine from which these by-products derived from hydrazine have been removed can be obtained. The crude body thus isolated usually has a purity of about 95 to 98%.

本発明の製造方法においては、晶析による精製工程を行う前に粗体の純度はできるだけ高くしておくことが好ましい。また、上記のような反応により得られる粗体には、晶析による除去が困難な着色成分を含まれることがあるので、晶析による精製を行う前に活性炭処理によりこのような着色成分を除去するのが好ましい。活性炭処理は、Lカルノシンの粗体の水溶液を活性炭と接触させた後に、活性炭を除去することにより行うことができる。   In the production method of the present invention, the purity of the crude product is preferably as high as possible before performing the purification step by crystallization. In addition, since the crude product obtained by the reaction as described above may contain coloring components that are difficult to remove by crystallization, such coloring components are removed by activated carbon treatment before purification by crystallization. It is preferable to do this. The activated carbon treatment can be performed by removing the activated carbon after bringing the crude aqueous solution of L carnosine into contact with the activated carbon.

このとき活性炭としては、試薬として或いは工業的に入手可能なものが特に制限なく使用できる。好適に使用できる活性炭を具体的に例示すれば、次のようなもの挙げることができる。   At this time, activated carbon that can be used as a reagent or industrially can be used without particular limitation. The following can be mentioned if the activated carbon which can be used conveniently is illustrated concretely.

日本ノーリット社のPK、PKDA MESY/MRX、ELORIT、AZ0、DARCO、HYDRODARCO 3000/4000、DARCO 12X20LI、DARCO12X20DC、PETRODARCO、DARCO MRX、GAC、GAC PLUS、DARCO VAPURE、GCN、C−GRANULAR等の破砕活性炭類、CA、CN、CG、DARCO KB/KBB、S−51、S−51−HF、S−51−FF、PREMIUM DARCO、DARCO GFP、HDC/HDR/HDH、GRO SAFE、FM−1、DARCO TRS、DARCO FGD、SX、SX ULTRA、SA、D−10、PN、ZN、SA−SW、W、GL、HB PLUS等の粉末活性炭類、ROW、RO、ROX、RB、R、R.EXTRA、SORBONORIT、GF 40/50、CNR、ROZ、RBAA、RBHG、RZN、RGM等の成型活性炭・添着活性炭類、PICA社の粒状活性炭類、球状活性炭類、粉末活性炭類、日本エンバイロケミカル社のモルシーボン、WHA、粒状白鷺(X2M、GM2X、GH2X、GHXUG、GS1X、GS3X、GTX、GTSX、G2X、GS2X、GAAX、MAC−W、GOC、GOX、GOHX、APRC、TAC、MAC、XRC、NCC、SRCX)等の機能性活性炭類、粒状白鷺(G2C、C2C、WH2C、W2C、WH5C、W5C、LGK−400、LGK−100、LH2C、KL、G2X、GH2X、WH2X、S2X、C2X、X7000H、X7100H、X700H−3、X7100H−3、LGK−700、DX7−3)、X−7000、X−7100、X−7000−3、X−7100−3、等の粒状活性炭類、白鷺(C、M、A、P、PHC、FAC−10)、カルボラフィン、強力白鷺、精製白鷺、精製白鷺2、特製白鷺、白鷺DO−2、白鷺DO−5、白鷺DO−11等の粉末活性炭類、ハニカムカーボ白鷺、モールドカーボン、カーボンペーパー、白鷺C−DC、カルボラフィンDC、粒状白鷺DC、アルデナイト、アルデナイトSP等の活性炭加工品類二村化学工業社のSG、SGP等の顆粒活性炭類、TA、TS、TG、TM等の造粒活性炭類、S、FC、SA1000、K、A、KA、AC、M、P、IC、IP、CB、GB、GLP、CLP、W等の粉末活性炭類、CG48B、CG48BR、CW130B、CW130A、CW130BR、CW130AR、CW480SZ、CW6100SZ、GL130A、GL240A、GM130A、GM240A、GMC等の破砕活性炭類。   Japan Norit PK, PKDA MESY / MRX, ELORIT, AZ0, DARCO, HYDRODARCO 3000/4000, DARCO 12X20LI, DARCO12X20DC, PETRODACO, DARCO MRX, GAC, GAC PLUS, GARCU VACURE, GARCU , CA, CN, CG, DARCO KB / KBB, S-51, S-51-HF, S-51-FF, PREMIUM darco, DARCO GFP, HDC / HDR / HDH, GRO SAFE, FM-1, DARCO TRS, Powdered activated carbons such as DARCO FGD, SX, SX ULTRA, SA, D-10, PN, ZN, SA-SW, W, GL, HB PLUS, ROW, RO, ROX, RB, R, R. Molded activated carbon and impregnated activated carbon such as EXTRA, SORBONORIT, GF 40/50, CNR, ROZ, RBAA, RBHG, RZN, RGM, etc., PICA granular activated carbon, spherical activated carbon, powdered activated carbon, Nippon Enviro Chemical's Molcybon , WHA, granular white birch (X2M, GM2X, GH2X, GHXUG, GS1X, GS3X, GTX, GTSX, G2X, GS2X, GAAX, MAC-W, GOC, GOX, GOX, APRC, TAC, MAC, XRC, NCC, SRCX) Functional activated carbon such as granular white birch (G2C, C2C, WH2C, W2C, WH5C, W5C, LGK-400, LGK-100, LH2C, KL, G2X, GH2X, WH2X, S2X, C2X, X7000H, X7100H, X700H- 3, X710 Granular activated carbons such as H-3, LGK-700, DX7-3), X-7000, X-7100, X-7000-3, X-7100-3, white birch (C, M, A, P, PHC) , FAC-10), carborafine, strong white birch, refined white birch, refined white birch, special white birch, white birch DO-2, white birch DO-5, white birch DO-11, etc., powdered activated carbon, honeycomb carbon white birch, molded carbon, carbon Activated carbon products such as paper, white birch C-DC, carborafine DC, granular white birch DC, aldenite, and aldenite SP Granular activated carbon such as SG and SGP from Nimura Chemical Industry, TA, TS, TG, TM, etc. Granular activated carbon, S, FC, SA1000, K, A, KA, AC, M, P, IC, IP, CB, GB, GLP, CLP, W, etc. Powdered activated carbon, CG48B, CG48BR, CW1 Crushed activated carbons such as 30B, CW130A, CW130BR, CW130AR, CW480SZ, CW6100SZ, GL130A, GL240A, GM130A, GM240A, GMC.

これらの中でも、CA、CN、CG、DARCO KB/KBB、S−51、S−51−HF、S−51−FF、PREMIUM DARCO、DARCO GFP、HDC/HDR/HDH、GRO SAFE、FM−1、DARCO TRS、DARCO FGD、SX、SX ULTRA、SA、D−10、PN、ZN、SA−SW、W、GL、HB PLUSや白鷺(C、M、A、P、PHC、FAC−10)、カルボラフィン、強力白鷺、精製白鷺、精製白鷺2、特製白鷺、白鷺DO−2、白鷺DO−5、白鷺DO−11等の粉末活性炭類が好適であり、特に白鷺(C、M、A、P)、精製白鷺、精製白鷺2、特製白鷺、CA、CN、CGが好適である。   Among these, CA, CN, CG, DARCO KB / KBB, S-51, S-51-HF, S-51-FF, PREMIUM DARCO, DARCO GFP, HDC / HDR / HDH, GRO SAFE, FM-1, DARCO TRS, DARCO FGD, SX, SX ULTRA, SA, D-10, PN, ZN, SA-SW, W, GL, HB PLUS, white birch (C, M, A, P, PHC, FAC-10), carbo Powdered activated carbons such as raffin, strong white birch, refined white birch, purified white birch 2, special white birch, white birch DO-2, white birch DO-5, white birch DO-11 are preferred, and white birch (C, M, A, P) in particular. Refined white birch, purified white birch 2, special white birch, CA, CN, CG are preferred.

これら活性炭の使用量は、着色成分の除去性及び経済性の観点から、L−カルノシンの質量に対して0.01〜10倍、好ましくは0.02〜5倍の質量とするのが好適である。   The amount of the activated carbon used is suitably 0.01 to 10 times, preferably 0.02 to 5 times the mass of L-carnosine, from the viewpoint of the removal of coloring components and the economical efficiency. is there.

粗体水溶液と活性炭との接触は流通法又はバッチ法で行うことができる。流通法では活性炭を充填した塔又はカラムに粗体水溶液を流通させればよい。また、バッチ法では、容器内で活性炭と粗体水溶液を混合すればよい。   The contact between the crude aqueous solution and the activated carbon can be performed by a flow method or a batch method. In the distribution method, the crude aqueous solution may be distributed through a column or column packed with activated carbon. In the batch method, activated carbon and a crude aqueous solution may be mixed in a container.

活性炭処理温度は、低温度ほど活性炭効果が出やすく好ましいが、L−カルノシンが結晶化してしまう恐れがあるため、通常−5℃〜40℃、好ましくは0〜30℃の範囲で行われる。活性炭処理時間は、あまり短いと充分な効果が得られず、あまり長くても、分解などにより不純物が増加する場合もあるため、通常0.1時間〜10時間、好ましくは0.5〜8時間の範囲で行われる。また、バッチ法を採用した場合における活性炭処理後の活性炭の分離は、濾過により行うことができる。   The activated carbon treatment temperature is preferably as the temperature is lower, but the activated carbon effect is more likely to occur, but L-carnosine may be crystallized, and thus is usually in the range of -5 ° C to 40 ° C, preferably 0 to 30 ° C. If the activated carbon treatment time is too short, a sufficient effect cannot be obtained, and even if it is too long, impurities may increase due to decomposition or the like, and therefore usually 0.1 hours to 10 hours, preferably 0.5 to 8 hours. It is done in the range. Moreover, the separation of the activated carbon after the activated carbon treatment when the batch method is employed can be performed by filtration.

このような活性炭処理を行うことにより着色成分が除去されたL−カルノシン粗体(通常、純度97〜99%)を得ることができる。   By performing such activated carbon treatment, a crude L-carnosine body (generally having a purity of 97 to 99%) from which colored components have been removed can be obtained.

本発明の製造方法は、必要に応じて活性炭処理を施したL−カルノシン粗体を下記(A)及び(B)の工程を含んでなる精製工程で精製する。   The manufacturing method of this invention refine | purifies the L-carnosine crude body which performed the activated carbon treatment as needed in the refinement | purification process which comprises the process of following (A) and (B).

(A) L−カルノシン粗体の水溶液とアルコールとを混合して得られた混合溶液にL−カルノシンの種結晶を添加し、30℃〜80℃で1〜10時間熟成させる熟成工程、及び
(B)前記工程で熟成された混合溶液にアルコールを加え、高純度化されたL−カルノシン結晶を析出させる結晶析出工程。
(A) A maturing step of adding a seed crystal of L-carnosine to a mixed solution obtained by mixing an aqueous solution of an L-carnosine crude material and an alcohol, and aging at 30 to 80 ° C. for 1 to 10 hours, and B) A crystal precipitation step of adding alcohol to the mixed solution aged in the above step to precipitate highly purified L-carnosine crystals.

粗体の水溶液に単にアルコールを添加してL−カルノシンの結晶を析出させた場合、或いは種結晶を加えて熟成を行う場合でも熟成条件が本発明で規定する条件から外れる場合には、99.5%以上の純度のL−カルノシンを高収率で得ることが困難である。また、種結晶を加えて熟成を行ってもそのまま冷却して結晶を析出させた場合には、収率が低下する。   In the case where L-carnosine crystals are precipitated by simply adding alcohol to the crude aqueous solution, or when ripening is carried out by adding seed crystals, the aging conditions deviate from the conditions defined in the present invention. It is difficult to obtain L-carnosine having a purity of 5% or more in high yield. Even if the seed crystal is added and ripened, if the crystal is precipitated by cooling as it is, the yield decreases.

前記工程(A)で使用するL−カルノシン粗体の水溶液におけるL−カルノシンの濃度は、高純度、高収率で精製できるという理由から、水溶液全体の質量を基準として5〜30質量%、特に10〜20質量%とするのが好ましい。   The concentration of L-carnosine in the aqueous solution of the crude L-carnosine used in the step (A) is 5 to 30% by mass based on the total mass of the aqueous solution, because it can be purified with high purity and high yield. It is preferable to set it as 10-20 mass%.

(A)工程において上記水溶液と混合されるアルコールとして、高純度で精製できるという理由から、炭素数1〜4の直鎖アルコールを使用するのが好ましい。好適に使用できるアルコールを具体的に例示すると、メタノール、エタノール、n−プロパノール、イソプロパノール、n−ブタノール、sec−ブタノール、tert−ブタノールが挙げられる。   As the alcohol mixed with the aqueous solution in the step (A), it is preferable to use a linear alcohol having 1 to 4 carbon atoms because it can be purified with high purity. Specific examples of the alcohol that can be suitably used include methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, and tert-butanol.

工程(A)において混合溶液を調製する際の水とアルコールの混合溶液の比率は、不純物除去性と収率のバランスから水:アルコールの比率が1:0.5〜1:10、特に1:1〜1:5となるようにするのが好ましい。粗体水溶液とアルコールとを混合する際に別途水を供給し濃度調節を行うことも可能である。不純物除去性、結晶の取り出し易さ、収率、及び一バッチあたりの収量の観点から、混合液中の含まれるL−カルノシンの濃度は、溶液全体の質量を基準として1〜15質量%、特に5〜10質量%とするのが好ましい。   The ratio of the mixed solution of water and alcohol when preparing the mixed solution in the step (A) is such that the ratio of water: alcohol is 1: 0.5 to 1:10, particularly 1: It is preferable that the ratio is 1: 1 to 1: 5. It is also possible to adjust the concentration by supplying water separately when mixing the crude aqueous solution and the alcohol. From the viewpoint of impurity removal property, ease of taking out crystals, yield, and yield per batch, the concentration of L-carnosine contained in the mixed solution is 1 to 15% by mass based on the total mass of the solution, particularly It is preferable to set it as 5-10 mass%.

混合溶液の調製は、L−カルノシン粗体の水溶液にアルコールを滴下するのが好ましい。アルコールにL−カルノシン粗体水溶液を滴下すると、滴下直後に結晶が析出することがあり高純度化が図れないことがある。アルコールを滴下するときの液温は、0〜100℃、特に5〜80℃に保つのが好適である。液温があまり低いと結晶化が促進され、アルコール滴下時に結晶化が起こり、不均一な純度を持ったL−カルノシンが形成される可能性があり、あまり高いと溶媒が蒸発してしまい、水とアルコールの比率が変化し、純度が低下することがある。   In preparing the mixed solution, alcohol is preferably added dropwise to the aqueous solution of the L-carnosine crude product. When a crude L-carnosine aqueous solution is dropped into alcohol, crystals may precipitate immediately after the dropping, and high purity may not be achieved. The liquid temperature when the alcohol is dropped is preferably kept at 0 to 100 ° C, particularly 5 to 80 ° C. If the liquid temperature is too low, crystallization is promoted, and crystallization occurs when alcohol is dripped, and L-carnosine having non-uniform purity may be formed. If it is too high, the solvent evaporates, And the ratio of alcohol may change, and the purity may decrease.

工程(A)においては、混合溶液を調製した後に種結晶を添加し、30〜80℃で1〜10時間熟成する必要がある。こうすることにより、より高純度なL−カルノシンを得ることが可能となる。種結晶の添加量は、あまり少ないと二次核が発生し、均一な結晶を得ることができず、あまり多くても経済的ではないため、通常、L−カルノシンの質量を基準として通常、0.001〜0.5倍、好ましくは0.005〜0.3倍の質量の種結晶を添加する。種結晶添加後の熟成温度は、30〜80℃であればよいが、さらに高純度で精製できるという理由から40〜70℃とするのが好ましい。温度や水とアルコールの比率、溶媒量にもよるが、熟成時間は1〜10時間程度で十分である。   In the step (A), it is necessary to add a seed crystal after preparing the mixed solution, and to age at 30 to 80 ° C. for 1 to 10 hours. By doing so, it becomes possible to obtain L-carnosine of higher purity. If the addition amount of the seed crystal is too small, secondary nuclei are generated, a uniform crystal cannot be obtained, and even if it is too much, it is not economical, and usually 0 based on the mass of L-carnosine. A seed crystal having a mass of 0.001 to 0.5 times, preferably 0.005 to 0.3 times is added. The aging temperature after seed crystal addition may be 30 to 80 ° C., but it is preferably 40 to 70 ° C. because it can be purified with higher purity. Although depending on the temperature, the ratio of water and alcohol, and the amount of solvent, a aging time of about 1 to 10 hours is sufficient.

工程(B)では、このようにして熟成した混合溶液にアルコールを加え、高純度化されたL−カルノシン結晶を析出させる。アルコールを添加せずに結晶を析出させた場合には収率を高くすることができない。このとき添加するアルコールとしては混合溶液調製時に使用したのと同種のアルコールを使用するのが好ましい。添加するアルコールの量は、純度、収率、経済性、及び一バッチあたりの収量の観点から、含有するL−カルノシンの質量に対して0.5〜15倍、特に1〜10倍の質量とするのが好ましい。   In the step (B), alcohol is added to the mixed solution thus aged to precipitate highly purified L-carnosine crystals. If crystals are precipitated without adding alcohol, the yield cannot be increased. As the alcohol to be added at this time, it is preferable to use the same kind of alcohol used in preparing the mixed solution. The amount of the alcohol to be added is 0.5 to 15 times, particularly 1 to 10 times the mass of the L-carnosine contained, from the viewpoints of purity, yield, economy, and yield per batch. It is preferable to do this.

(B)工程では、収率を高くするため、アルコールを滴下後、溶液を冷却するのが好ましい。このとき、純度及び生成効率の観点から冷却速度は、0.01℃/分〜5℃/分、特に0.05℃/分〜2℃/分とするのが好ましい。冷却による最終到達温度は、−10〜30℃、特に0〜25℃とするのが好ましく、最終到達温度で1〜2時間保持することにより高純度のL−カルノシンを高収率で回収することができる。   In the step (B), in order to increase the yield, it is preferable to cool the solution after dropping the alcohol. At this time, the cooling rate is preferably 0.01 ° C./min to 5 ° C./min, particularly 0.05 ° C./min to 2 ° C./min from the viewpoint of purity and production efficiency. The final temperature achieved by cooling is preferably −10 to 30 ° C., particularly preferably 0 to 25 ° C., and high purity L-carnosine is recovered in a high yield by maintaining the final achieved temperature for 1 to 2 hours. Can do.

このようにして析出したL−カルノシンの結晶は、ろ過や遠心分離などにより固液分離し、自然乾燥、送風乾燥、真空乾燥などにより乾燥することにより単離される。   The crystals of L-carnosine thus precipitated are isolated by solid-liquid separation by filtration, centrifugation, or the like, and drying by natural drying, air drying, vacuum drying, or the like.

以下、実施例を挙げて本発明を詳細に説明するが、本発明はこれらの実施例によって何等制限されることはない。   EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not restrict | limited at all by these Examples.

製造例1
攪拌羽、温度計、ガス吸収装置を備えた1,000ml四つ口フラスコにフタロイル−β−アラニン107g(0.488mol)を加え、N,N‘−ジメチルホルムアミド10ml存在下、二塩化オキサリル600mlを加え、室温で2時間攪拌後、二塩化オキサリルを真空留去し、黄色結晶を得た(1)。別の1,000ml四つ口フラスコにL−ヒスチジン62.08g(0.40mol)、1,1,1,3,3,3−ヘキサメチルジシラザン256ml(1.2mol)、濃硫酸0.1ml加え、還流下30分間攪拌した。冷却後、キシレン150ml加え、75℃で溶媒留去し、残渣をクロロホルム80mlで再結晶した(2)。1をクロロホルム400mlに溶解し、(2)に滴下し、室温で8時間攪拌した。攪拌後エタノール400ml加え30分攪拌後、結晶をろ過し154gのフタロイル−L−カルノシン塩酸塩を得た。
Production Example 1
Add 107 g (0.488 mol) of phthaloyl-β-alanine to a 1,000 ml four-necked flask equipped with a stirring blade, thermometer, and gas absorption device, and add 600 ml of oxalyl dichloride in the presence of 10 ml of N, N′-dimethylformamide. In addition, after stirring at room temperature for 2 hours, oxalyl dichloride was distilled off under vacuum to obtain yellow crystals (1). In another 1,000 ml four-necked flask, 62.08 g (0.40 mol) of L-histidine, 256 ml (1.2 mol) of 1,1,1,3,3,3-hexamethyldisilazane, 0.1 ml of concentrated sulfuric acid The mixture was further stirred for 30 minutes under reflux. After cooling, 150 ml of xylene was added, the solvent was distilled off at 75 ° C., and the residue was recrystallized from 80 ml of chloroform (2). 1 was dissolved in 400 ml of chloroform, added dropwise to (2), and stirred at room temperature for 8 hours. After stirring, 400 ml of ethanol was added and stirred for 30 minutes, and then the crystals were filtered to obtain 154 g of phthaloyl-L-carnosine hydrochloride.

1,000ml四つ口フラスコにメタノール800ml、水酸化リチウム1水和物17.1gとフタロイル−L−カルノシン塩酸塩154gを加え、室温で30分間攪拌し、還流下15分間攪拌した。冷後、結晶をろ過し、乾燥した結果、フタロイル−L−カルノシン138g得た。   To a 1,000 ml four-necked flask were added 800 ml of methanol, 17.1 g of lithium hydroxide monohydrate and 154 g of phthaloyl-L-carnosine hydrochloride, and the mixture was stirred at room temperature for 30 minutes and stirred for 15 minutes under reflux. After cooling, the crystals were filtered and dried to obtain 138 g of phthaloyl-L-carnosine.

1,000ml四つ口フラスコにフタロイル−L−カルノシン138g、ヒドラジン水和物23ml(0.46mol)、水460ml投入し、還流下1時間攪拌した。その後、酢酸31mlを滴下し10分間攪拌し、冷却した。得られた固体をろ過で除去し、pHを調節後、エタノールにより再沈殿し、さらに水を加えて黄色味を帯びたL−カルノシン粗体水溶液(L−カルノシン81.2g/水406g)を得た。なお、L−カルノシンのHPLC純度は97.9%であった。   A 1,000 ml four-necked flask was charged with 138 g of phthaloyl-L-carnosine, 23 ml (0.46 mol) of hydrazine hydrate, and 460 ml of water, and stirred for 1 hour under reflux. Thereafter, 31 ml of acetic acid was added dropwise, stirred for 10 minutes and cooled. The obtained solid was removed by filtration, the pH was adjusted, and then reprecipitated with ethanol. Further, water was added to obtain a yellowish L-carnosine crude aqueous solution (L-carnosine 81.2 g / water 406 g). It was. The HPLC purity of L-carnosine was 97.9%.

実施例1
攪拌羽と温度計を備えた1,000ml四つ口フラスコに製造例1で得たL−カルノシン粗体水溶液を、5℃に冷却後、日本エンバイロケミカル社製活性炭白鷺Aを8.1g加え、2時間攪拌した。攪拌後活性炭をろ過し、活性炭を20mlの水で洗浄し、無色澄明水溶液を得た。該水溶液に含まれるL−カルノシンのHPLC純度は99.0%であった。
Example 1
After cooling the L-carnosine crude aqueous solution obtained in Production Example 1 to a 1,000 ml four-necked flask equipped with a stirring blade and a thermometer at 5 ° C., 8.1 g of activated carbon white lees A manufactured by Nippon Environment Chemical Co., Ltd. was added. Stir for 2 hours. After stirring, the activated carbon was filtered, and the activated carbon was washed with 20 ml of water to obtain a colorless and clear aqueous solution. The HPLC purity of L-carnosine contained in the aqueous solution was 99.0%.

攪拌羽と温度計を備えた2,000ml四つ口フラスコに活性炭処理後のL−カルノシン粗体水溶液505gを加え、50℃に昇温し、メタノール730mlを30分間かけて滴下した。次いで混合溶液に種結晶を1.4g添加し、50℃で2時間熟成した。結晶が充分成長している事を確認してから新たにメタノール406mlを30分かけて滴下し、0.4℃/分のスピードで5℃まで冷却し、5℃で1時間保持した。その後、析出したL−カルノシンの結晶をろ過し、真空乾燥を行った結果、73.6g(精製収率90.7%)、HPLC純度99.87%の白色L−カルノシンが得られた。   To a 2,000 ml four-necked flask equipped with a stirring blade and a thermometer, 505 g of a crude aqueous solution of L-carnosine after activated carbon treatment was added, the temperature was raised to 50 ° C., and 730 ml of methanol was added dropwise over 30 minutes. Next, 1.4 g of seed crystals were added to the mixed solution and aged at 50 ° C. for 2 hours. After confirming that the crystals were sufficiently grown, 406 ml of methanol was newly added dropwise over 30 minutes, cooled to 5 ° C. at a speed of 0.4 ° C./min, and kept at 5 ° C. for 1 hour. Thereafter, the precipitated crystals of L-carnosine were filtered and vacuum-dried. As a result, white L-carnosine with 73.6 g (purification yield: 90.7%) and HPLC purity of 99.87% was obtained.

実施例2
製造例1と同様の方法で得たL−カルノシン水溶液使用し、活性炭に日本ノーリット社製CAを8.1g使用した以外は実施例1と同様の操作を行った。その結果、73.2g(精製収率90.1%)、HPLC純度99.85%の白色L−カルノシンが得られた。
Example 2
The same operation as in Example 1 was performed, except that an L-carnosine aqueous solution obtained by the same method as in Production Example 1 was used, and 8.1 g of CA manufactured by Japan Norit was used for the activated carbon. As a result, white L-carnosine having 73.2 g (purification yield: 90.1%) and HPLC purity of 99.85% was obtained.

実施例3
製造例1と同様の方法で得たL−カルノシン水溶液使用し、アルコールにエタノールを使用した以外は実施例1と同様の操作を行った。その結果、73.2g(精製収率90.2%)、HPLC純度99.80%の白色L−カルノシンが得られた。
Example 3
The same operation as in Example 1 was performed except that an aqueous L-carnosine solution obtained by the same method as in Production Example 1 was used and ethanol was used as the alcohol. As a result, white L-carnosine having 73.2 g (purification yield: 90.2%) and HPLC purity of 99.80% was obtained.

実施例4
製造例1と同様の方法で得たL−カルノシン水溶液使用し、アルコールにイソプロパノールを使用した以外は実施例1と同様の操作を行った。その結果、73.3g(精製収率90.3%)、HPLC純度99.86%の白色L−カルノシンが得られた。
Example 4
The same operation as in Example 1 was performed except that an L-carnosine aqueous solution obtained by the same method as in Production Example 1 was used and isopropanol was used as the alcohol. As a result, white L-carnosine having 73.3 g (purification yield 90.3%) and HPLC purity 99.86% was obtained.

比較例1
製造例1と同様の方法で得たL−カルノシン水溶液使用し、熟成温度を20℃で行った以外は実施例1と同様の操作を行った。その結果、73.2g(精製収率90.2%)、HPLC純度99.13%のL−カルノシンが得られ、あまり精製されなかった。
Comparative Example 1
The same operation as in Example 1 was performed except that the L-carnosine aqueous solution obtained by the same method as in Production Example 1 was used and the aging temperature was 20 ° C. As a result, L-carnosine having 73.2 g (purification yield: 90.2%) and HPLC purity of 99.13% was obtained and not very purified.

比較例2
製造例1と同様の方法で得たL−カルノシン水溶液使用し、熟成を行わずに種結晶を加えてから直ちにメタノールに滴下して結晶を析出させた他は実施例1と同様の操作を行った。その結果、73.3g(精製収率90.3%)、HPLC純度99.0%のL−カルノシンが得られ、ほとんど精製されなかった。
Comparative Example 2
The same operation as in Example 1 was performed, except that an aqueous L-carnosine solution obtained in the same manner as in Production Example 1 was used, seed crystals were added without aging, and then immediately dropped into methanol to precipitate crystals. It was. As a result, L-carnosine having 73.3 g (purification yield: 90.3%) and HPLC purity of 99.0% was obtained and hardly purified.

比較例3
製造例1と同様の方法で得たL−カルノシン水溶液使用し、熟成後にメタノールを加えなかった以外は実施例1と同様の操作を行った。その結果、62.8g(精製収率77.3%)、HPLC純度99.91%の白色L−カルノシンが得られ、収率が低下した。
Comparative Example 3
The same operation as in Example 1 was performed, except that an aqueous L-carnosine solution obtained by the same method as in Production Example 1 was used, and methanol was not added after aging. As a result, white L-carnosine with 62.8 g (purification yield: 77.3%) and HPLC purity of 99.91% was obtained, and the yield was lowered.

Claims (3)

不純物を含むL−カルノシンの粗体を精製する精製工程を含むL−カルノシンの製造方法であって、前記精製工程が、前記粗体の水溶液とアルコールとを混合して得られた混合溶液にL−カルノシンの種結晶を添加し、30℃〜80℃で1〜10時間熟成させる熟成工程と、前記工程で熟成された混合溶液にアルコールを加え、高純度化されたL−カルノシン結晶を析出させる結晶析出工程とを、含むことを特徴とする方法。 A method for producing L-carnosine comprising a purification step of purifying a crude L-carnosine containing impurities, wherein the purification step comprises adding an aqueous solution of the crude and an alcohol to a mixed solution obtained by mixing L -Adding a seed crystal of carnosine and aging for 1 to 10 hours at 30 ° C to 80 ° C, and adding alcohol to the mixed solution aged in the above step to precipitate highly purified L-carnosine crystals A crystal precipitation step. 前記熟成工程の前工程として不純物を含むL−カルノシンの粗体の水溶液を活性炭処理する工程を更に含む請求項1に記載の方法。 The method according to claim 1, further comprising a step of subjecting a crude aqueous solution of L-carnosine containing impurities to an activated carbon treatment as a previous step of the aging step. フタロイル−β―アラニンの酸クロライドとトリメチルシリル基で保護されたL−ヒスチジンとを反応さて得たフタロイル−L−カルノシンをヒドラジンで脱保護することにより不純物を含むL−カルノシンの粗体を得る工程を更に含む、請求項1又は2に記載の方法。
Obtaining a crude product of impure L- carnosine by deprotecting the protected L- histidine and phthaloyl -L- carnosine obtained by reacting an acid chloride with a trimethylsilyl group of phthaloyl -β- alanine with hydrazine The method according to claim 1, further comprising a step.
JP2005215661A 2005-07-26 2005-07-26 Method for producing L-carnosine Active JP4540568B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005215661A JP4540568B2 (en) 2005-07-26 2005-07-26 Method for producing L-carnosine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005215661A JP4540568B2 (en) 2005-07-26 2005-07-26 Method for producing L-carnosine

Publications (3)

Publication Number Publication Date
JP2007031328A JP2007031328A (en) 2007-02-08
JP2007031328A5 JP2007031328A5 (en) 2010-07-01
JP4540568B2 true JP4540568B2 (en) 2010-09-08

Family

ID=37791004

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005215661A Active JP4540568B2 (en) 2005-07-26 2005-07-26 Method for producing L-carnosine

Country Status (1)

Country Link
JP (1) JP4540568B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106366158A (en) * 2016-08-31 2017-02-01 精晶药业股份有限公司 Crystallization method of carnosine
CN106366159A (en) * 2016-08-31 2017-02-01 精晶药业股份有限公司 Carnosine extracting and purifying method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009139392A1 (en) 2008-05-12 2009-11-19 味の素株式会社 PROCESS FOR PRODUCTION OF β-ALANYLAMINO ACID OR DERIVATIVE THEREOF
JP5448588B2 (en) * 2009-06-12 2014-03-19 株式会社トクヤマ Method for purifying L-carnosine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034011A1 (en) * 1995-04-27 1996-10-31 Dainippon Pharmaceutical Co., Ltd. Purifying methods
JP2003509437A (en) * 1999-09-15 2003-03-11 アストラゼネカ・アクチエボラーグ Method for producing H-TYR-D-ALA-PHE (F) -PHE-NH2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58124750A (en) * 1982-01-21 1983-07-25 Ajinomoto Co Inc Preparation of n-acyl-l-carnosine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034011A1 (en) * 1995-04-27 1996-10-31 Dainippon Pharmaceutical Co., Ltd. Purifying methods
JP2003509437A (en) * 1999-09-15 2003-03-11 アストラゼネカ・アクチエボラーグ Method for producing H-TYR-D-ALA-PHE (F) -PHE-NH2

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106366158A (en) * 2016-08-31 2017-02-01 精晶药业股份有限公司 Crystallization method of carnosine
CN106366159A (en) * 2016-08-31 2017-02-01 精晶药业股份有限公司 Carnosine extracting and purifying method

Also Published As

Publication number Publication date
JP2007031328A (en) 2007-02-08

Similar Documents

Publication Publication Date Title
JP4114200B2 (en) Method for producing nateglinide crystals
JP4540568B2 (en) Method for producing L-carnosine
JPH0331258A (en) Purification of tryptophan
JP4322621B2 (en) Process for producing 4'-cyano-3-[(4-fluorophenyl) sulfonyl] -2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide
JP2011006379A (en) Method for recrystallizing {2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylic acid-3-[1-(diphenylmethyl)azetidin-3-yl]ester-5-isopropyl ester}(azelnidipine), isopropyl alcohol adduct of azelnidipine, and method for producing azelnidipine
JPS62164672A (en) Production of 1,2-dimethylimidazole
JP4892821B2 (en) Epalrestat manufacturing method
JP2012020970A (en) Method for producing {3-(1-diphenylmethylazetidin-3-yl)ester-5-isopropyl ester 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate}
JP2007031328A5 (en)
SI9620018A (en) Process for producing n-(d-alpha-methyl-beta-mercaptopropionyl)-l-proline and its intermediate
JP5952748B2 (en) Novel crystalline form of phthaloyl amlodipine and process for producing high purity amlodipine besylate using the same
JP5448588B2 (en) Method for purifying L-carnosine
JP2018502858A (en) Method for producing forodesin
US8129536B2 (en) Method for the purification of lansoprazole
JP6711709B2 (en) Method for producing ezetimibe
JPH10245352A (en) Purification of biscresol compounds
JPH08143585A (en) Purification of o,s-dimethyl-n-acetylphosphoramide thioate
JP5397706B2 (en) Method for producing high purity 1-benzyl-3-aminopyrrolidine
JP4514017B2 (en) Method for producing epinastine hydrochloride
JP2010105935A (en) METHOD FOR PURIFYING 4-(8-CHLORO-5,6-DIHYDRO-11H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDIN-11-YLIDENE)-1-PIPERIDINECARBOXYLIC ACID ETHYL ESTER
JP3815064B2 (en) Method for purifying 1- (4-chlorobenzoyl) -5-methoxy-2-methylindole-3-acetic acid
CN108069971B (en) Refining method of pralatrexate intermediate
JP5836851B2 (en) Method for producing brinzolamide
JPH07238063A (en) Method for recovering and purifying 5-aminolevulinic acid
JP6227963B2 (en) Method for producing crystals of montelukast dipropylamine salt

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070816

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100518

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100601

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100622

R150 Certificate of patent or registration of utility model

Ref document number: 4540568

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130702

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130702

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160702

Year of fee payment: 6